0 Comments
Thermoregulation is the ability to balance heat production and heat loss in order to maintain body temperature within a certain normal range. Thermoregulation in the neonate is a critical physiological function that is strongly influenced by physical immaturity, extent of illness, and environmental factors. The average normal axillary temperature is considered to be 37°C and normal temperature in neonates is about 36.4C (97.5F). However, temperature can vary slightly ranging between 36.7 - 37.3°C. It is important that neonates should be nursed within their neutral thermal environment’ (NTE). Thermal temperature can be categorized into hypothermia and hyperthermia. Hypothermia occurs when a newborn’s body temperature drops below 36.5°C (97.7°F) while Hyperthermia is characterized by an uncontrolled increase in body temperature that exceeds the body's capacity to lose heat. Multiple techniques have been used to assess thermoregulation in infants and to provide thermo-neutral environment to maintain normal body temperature in neonates.
Neonatal Thermoregulation Devices Market Drivers The major factor driving growth of the neonatal thermoregulation devices market is increase in incidence of preterm birth, which result in low body temperature, especially immediately after birth in the delivery room, due to a lack of stored body fat. For instance, in 2017, according the data provided by National Center for Health Statistics (NCHS), preterm birth rate in the US was 9.93%. Premature birth and complications associated with it are major contributors to infant death in this country. Moreover, technological advancement in medical devices has also been a major driver for the neonatal thermoregulation devices market growth. Furthermore, growth in number of Neonatal Intensive Care Unit (NICU) admissions and Special Care Nursery (SCN) has further accelerated the demand for neonatal incubators to initiate the proper treatment for newborn and premature babies at the earliest. For instance, in 2014, according to the report by Australian Institute of Health and Welfare’s Australia’s Mothers and Babies, around 72% of pre-term babies are more likely to be admitted to an SCN or NICU than term (10%) and post term babies (13%). Get HOLISTIC Request Sample Copy Of This Business Report: https://www.coherentmarketinsights.com/insight/request-sample/2419 Neonatal Thermoregulation Devices Market Restraints However, potential hazards occurring in neonates due to use of the warmers is expected to restrain growth of the market. For instance, in 2013, American Academy of Pediatrics (AAP) stated that most serious complication while using radiant warmers is extreme hyperthermia, which may occur from improper use or from dislodgement of the sensor probe, which result in death or permanent neurological damage in infants. Neonatal Thermoregulation Devices Market- Regional Analysis On the basis of region, the global neonatal thermoregulation devices market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. Geographically, North America is projected to gain major share in the neonatal thermoregulation devices market, owing to increasing incidences of preterm birth. For instance, in March 2017, according to Dimes survey, 1 in 10 babies was born preterm in the U.S. Asia Pacific is expected to hold the significant market share in neonatal thermoregulation devices market, owing to developing neonatal healthcare facility in this region. Also, the multinational companies are primarily targeting the Asian markets for developing neonatal care devices owing to lower manufacturing cost in this region. For instance, in 2013, Koninklijke Philips N.V. entered the mother and childcare business segment, where it manufactures infant warms and incubators at affordable prices as compared to other market players in India. Key players operating in neonatal thermoregulation market include GE Healthcare, Natus Medical Incorporated, Inspiration Healthcare Group plc. Koninklijke Philips N.V., Dragerwerk AG & Co. KGaA, Fisher & Paykel Healthcare, Atom Medical Corporation, Fanem Ltda, Novos Medical Systems, Pluss Advanced Technologies Pvt. Ltd., Weyer GmbH, Baby Bloom Healthcare BV, and Medical Technology Transfer and Services Asia Click To Reading More On Neonatal Thermoregulation Devices Market About Coherent Market Insights: Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us: Mr.Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email:[email protected] Veterinary/Animal vaccines are parenteral products that are used as prophylactic as well as in treatment of various veterinary diseases. Veterinary vaccines play a crucial role in ensuring good health, longevity, and improving overall productivity of pets and livestock, in a cost-effective manner. It also plays an extremely important role in curtailing incidence of transmission of various diseases from animals to humans. Vaccines are broadly classified as inactivated vaccines, toxoid vaccines, live attenuated vaccines, conjugated vaccines, subunit and DNA vaccines. Inactivated vaccines are considered as safe vaccines, though they contain extraneous proteins or adjuvants, which can increase risk for development of acute vaccine reactions. Veterinary vaccines impact animal health and production quality and also help ensure good health of general human population through consumption of various food procured from animals. The continued interaction between animals and health professionals are the major importance for adaption of novel technologies in heath sector by providing animal models of disease.
Request For Sample Copy Market Dynamics: Rapid increase in population of companion animals and livestock animals globally is one of the major factors expected to favor market growth for veterinary vaccines. Rise in awareness about the vaccination programs are further favoring growth of the global veterinary vaccines market. The market is estimated to witness considerable revenue traction over the forecast period, due to increasing incidence of food-borne zoonotic diseases worldwide. Also, rise in demand for white meat in the North American and European countries is in turn expected to support growth of the veterinary vaccines market in the near future. According to the PoultrySite - Poultry News, Health, Welfare, Diseases, Markets and Economics, in 2013, there was a significant rise in demand for white meat in Italy since a decade, with demand for turkey, chicken and eggs increased by 8.5%, while production of poultry increased by 16%. Market Taxonomy: This report segments the global veterinary vaccines market on the basis of technology, animal type and geography. On the basis of product type, the market is categorized into inactivated vaccines, toxoid vaccines, live attenuated vaccines, conjugated vaccines, subunit and DNA vaccines. On the basis of animal type, the market is segmented into companion animal and livestock animal. The companion animal type segment is sub-segmented into equine, canine, and feline. The livestock animal type segment is further sub-segmented into bovine, ovine, porcine, poultry and other animals. For comprehensive understanding of market dynamics, the global veterinary vaccines market is analyzed across key geographical regions namely North America, Europe, Asia Pacific, Latin America, Africa, and Middle East. Each of these regions is analyzed on basis of market findings across major countries in these regions for a macro-level understanding of the market. Key companies covered as a part of this study include, Zoetis Inc. Merck Animal Health, Merial Inc. , Boehringer Ingelheim , Bayer Animal Health, Elanco Animal Health, Ceva Animal Health, Heska Corporation, Virbac Inc., and Indian Immunological Ltd. Detailed Segmentation: Global Veterinary Vaccines Market, By Technology Type: • Inactivated Vaccines • Toxoid Vaccines • Live Attenuated Vaccines • Subunit and DNA Vaccines • Conjugated Vaccines Global Veterinary Vaccines Market, By Animal Type: • Companion Animal • Equine • Canine • Feline • Livestock Animal • Bovine • Ovine • Porcine • Poultry • Others Global Veterinary Vaccines Market, By Geography: • North America • Latin America • Europe • Asia Pacific • Middle East • Africa If You Have Specific Requirement? Ask Our Experts @ https://www.coherentmarketinsights.com/insight/talk-to-analyst/125 About Coherent Market Insights: Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us: Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email: [email protected] Until about a decade ago, skin diseases were not considered to be much of a concern among the medical fraternity, with focus mainly towards combating major diseases such as HIV/AIDS and hospital-acquired pneumonias. However, in primary care settings, skin disorders are the common diseases prevalent in tropical areas. HIV infection related skin diseases are especially common in sub-Saharan geographies. In 2015, according to Turkish Journal of Family Medicine & Primary Care, infections related to skin are common worldwide with a prevalence of pyoderma between 0.2% and 35%, for tinea capitis it is around 19.7%, for scabies it ranges between 0.2% and 24%, and for viral skin disorders it ranges between 0.4% and 9%.
Market Dynamics Rise in number of skin infections and rise in demand for skin rejuvenation is expected to propel growth of the dermatology disease market. Rise in demand for skin rejuvenation therapy is backed up by increasing use of radiofrequency techniques, which in turn is expected to favor the market for dermatology devices market in the near future. Furthermore, high prevalence of skin mycoses globally is projected to have a positive effect on the growth for dermatology devices market. According to article published in 2008 by John Wiley & Sons, Inc., high prevalence of skin mycoses was around 20–25% and thus, was considered as one of the most prevalent forms of infection worldwide. The last decade has witnessed a spurt in incidence of skin diseases caused by pathogens such as anthropophilic and zoophilic dermatophytesm, which are especially prevalent in regions tropical regions due to the favorable growth environment. Also, change in lifestyle and awareness about the treatment is also one of the major factor affecting positively the growth of dermatology devices market. Scar and tattoo removal are some of the examples that require dermatology devices. According to Deccan Chronicles, in 2016, there were 25,000 tattoo removal cases recorded in India of the 128,218 cases worldwide, as revealed by a survey conducted by the International Society of Aesthetic Plastic Surgery (ISAPS) in 2015. Advancement in technology is expected to be a threat for conventional treatment methods in the dermatology devices market The treatment procedures that are minimally invasive are gaining attention in the medical community and among patients, worldwide. Therefore, there is a high demand for devices such as microdermabrasion, pens for pigmented lesions, scars, and loose skin, and laser therapy globally. The conventional surgical procedures used for the treatment of skin disorders are replaced with these devices, as conventional procedures leaves out unwanted scars post-surgery. Some of the safe and effective treatment options for acne scarring include laser resurfacing, dermabrasion, and chemical peels. Researches based on the effectiveness of laser and light therapies in treating mild to moderate acne is still going on. PMD Beauty pioneered the at-home microdermabrasion device that allows users to perform microdermabrasion procedure at ease and convenient. The device has a large consumer base in the U.S., U.K. and Australia. Market Taxonomy This report segments the global dermatology devices market on the basis of product type, application, end user, and geography. On the basis of product type, the market is categorized into microdermabrasion devices, lasers and others. The laser product type segment is sub-segmented into alexandrite laser, diode, fractional, infrared 1319 nm, nd:yag 1064 nm, potassium titanyl phosphate (ktp), pulsed. The application segment is divided into vascular lesions, scar removal, tattoo removal, hair removal, wrinkle removal, acne treatment, skin rejuvenation, pore reduction and others. The vascular lesions application segment is further divided into telangiectasia, hemangiomas, port wine stains and venous lakes and scar removal application segment is sub-divided into red or hypertrophic scars and hyper-pigmentation. For comprehensive understanding of market dynamics, the global dermatology market is analyzed across key geographical regions namely North America, Europe, Asia Pacific, Latin America, Africa, and Middle East. Each of these regions is analyzed on basis of market findings across major countries in these regions for a macro-level understanding of the market. Download PDF Brochure of Research Report @ https://www.coherentmarketinsights.com/insight/request-pdf/117 Market Players This is expected to benefit the dermatology devices market players such as Valeant Pharmaceuticals International Inc., Lumenis, Ltd., Cynosure Inc., Syneron Candela Ltd., Avita Medical Ltd., Alma Lasers, Ltd., Lutronics Corporation, Beijing Toplaser Technology Co. Ltd., Shanghai Fosun Pharmaceutical Group Co. Ltd., and Cutera, Inc. Detailed Segmentation: Global Dermatology Devices Market, By Product Type: • Microdermabrasion Devices • RF Devices • Lasers - Alexandrite laser - Diode - Fractional - InfraRed 1319 nm - Nd:YAG 1064 nm - Potassium Titanyl Phosphate (KTP) - Pulsed • Others Global Dermatology Devices Market, By Application: • Vascular Lesions - Telangiectasia - Hemangiomas - Port wine stains - Venous lakes • Scar Removal - Red or hypertrophic scars - Hyperpigmentation • Tattoo removal • Hair removal • Wrinkle Removal • Acne Treatment • Skin Rejuvenation • Pore Reduction • Others Global Dermatology Devices Market, By End User: • Hospitals • Specialty Dermatology Clinics • Private Clinics Global Dermatology Devices Market, By Geography: • North America • Latin America • Europe • Asia Pacific • Middle East • Africa Else place an Enquiry Before Purchase " Dermatology Devices Market Size, Share, Outlook, Forecast" Report @ https://www.coherentmarketinsights.com/insight/talk-to-analyst/117 About Coherent Market Insights: Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us: Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email: [email protected] Gastric and esophageal cancers are characterized by growth of malignant (cancerous) cells, forming a tumor, within the lining of stomach and esophagus. Smoking, excessive alcohol consumption, and Barrett’s esophagus can causes gastric and esophageal cancers. Symptoms of gastric and esophageal cancers include difficulty in swallowing (dysphagia), weight loss, chest pain, indigestion or heartburn, coughing or hoarseness, pain behind the breastbone. Early stage of gastric and esophageal cancer does not show any of this signs and symptoms.
Increasing number of cancer drugs in pipeline studies and rising involvement of key players for development of cancer treatment are expected to propel gastric and esophageal cancer drugs market growth. For instance, in April 2016, Centre Hospitalier Universitaire de Besancon, initiated Phase 1 and Phase 2 clinical trial for Carboplatin to determine the maximum tolerated dose (MTD) and recommended doses for phase II (RP2D) by considering the treatment scheme of Dutch study for chemotherapy and radiotherapy. The study is conducted in elderly patients with esophagus cancer. Carboplatin is an anticancer chemotherapy drug from alkylating agent category. The study is estimated to complete by April 2024. Moreover, in February 2017, Henan Cancer Hospital in collaboration with Jiangsu HengRui Medicine Co., Ltd., initiated Phase 2 exploratory clinical trial to evaluate the efficacy of Apatinib, treatment for advanced esophagus cancer. Apatinib is a tyrosine kinase inhibitor that selectively inhibits the vascular endothelial growth factor receptor-2(VEGFR2). However, high cost of therapy for the treatment of gastric and esophageal cancers is expected to restraint the market growth. For instance, as per the report published in Healthday, in 2013, cancer patients paid US$ 207,000 a year for the treatment and medications while in 1995 the cost was US$ 54,100 a year. Get HOLISTIC Request Sample Copy Of This Business Report: https://www.coherentmarketinsights.com/insight/request-sample/2438 Gastric and Esophageal Cancer Drugs Market- Regional Analysis On the basis of region, the global gastric and esophageal cancer drugs market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. Geographically, North America is expected to be the leading region in the gastric and esophageal cancer drugs market during the forecast period, owing to high prevalence of esophageal cancer in this region. For instance, the American Cancer Society’s estimated that about 17,650 new esophageal cancer cases in the U.S. will be diagnosed (13,750 in men and 3,900 in women) by 2019. Moreover, mergers and acquisitions activities by key players in this region are expected to propel the market growth during the forecast period. For instance, in December 2018, GlaxoSmithKline plc announced the acquisition of TESARO Inc, an oncology focused company based in Massachusetts, U.S. This acquisition is expected to strengthen GSK’s pharmaceutical business by accelerating GSK’s pipeline and commercial capability in oncology. Key players in Europe are focused on various business strategies such as acquisitions and mergers, which in turn boosts growth of the market. For instance, in September 2018, Boehringer Ingelheim acquired all shares of ViraTherapeutics, an Austria-based biopharmaceutical company, specializing in the development of oncolytic viral therapies. The total transaction value for this acquisition was US$ 240.52 million. This acquisition strengthened Boehringer Ingelheim’s commitment to research and development for viral-based immuno-oncology treatment. Key players for gastric and esophageal cancer drugs market includes Amgen, Eli Lilly and Company, F. Hoffmann-La Roche, Bristol-Myers Squibb Company, Boehringer Ingelheim GmbH, Bristol-Myers Squibb, GlaxoSmithKline Plc., Novartis AG, Johnson & Johnson, Gilead Sciences, Merck & Co. and others. Click To Reading More On Gastric and Esophageal Cancer Drugs Market About Coherent Market Insights: Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us: Mr.Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email:[email protected] 1/29/2019 Antimicrobial Susceptibility Testing Market - Size, Share, Outlook and Current TrendsRead NowThe global antimicrobial susceptibility testing market size was valued at US$ 2.65 billion in 2017 and is expected to witness a CAGR of 6.2% over the forecast period (2018 – 2026).
Resistance among various microbial species to different antimicrobial drugs have emerged as a major cause of public health threat. According to World Health Organization (WHO), these resistant microorganisms such as bacteria, fungi, viruses, and parasites are able to combat attack by antimicrobial drugs, which leads to ineffective treatment resulting in persistence and spreading of infections. Increasing number of multidrug resistance cases in tuberculosis (TB), malaria, HIV, influenza, and others among the global population is expected to result in increasing adoption of antimicrobial susceptibility testing to reduce the resistance exposure during the forecast period. For instance, according to the WHO, in 2016, an estimated 490,000 people worldwide developed MDR-TB. The countries with the largest numbers of MDR/RR-TB cases were China, India and the Russian Federation. Moreover, development of genotypic-based methods offering rapid and accurate detection or confirmation of antimicrobial resistance is expected to drive the market growth. For instance, the Accelerate ID/AST System or ID/AST System (Accelerate) aims to reduce the turnaround time by using genetic methods. The device can identify infectious pathogens in a matter of hours instead of days, reducing diagnostic time by 30 to 50 hours. Get HOLISTIC Request Sample Copy Of This Business Report: https://www.coherentmarketinsights.com/insight/request-sample/2449 Antimicrobial Susceptibility Testing Market Restraints Stringent government regulations is the major restraining factor for the antimicrobial susceptibility testing market growth. Regulatory procedures creates barrier to AST development, as clinical validation and trials are lengthy and often too costly for small-sized or medium-sized enterprises or organizations. For instance, in the U.S., a manufacturer who intends to market a device of generic type must conform to the general controls of Section 513(a)(1)(B) of the Federal Food, Drug and Cosmetic Act, address the risks to health associated with the AST system, and obtain a substantial equivalence assessment from the FDA. Antimicrobial Susceptibility Testing Market - Regional Insights On the basis of region, the global antimicrobial susceptibility testing market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to be the most lucrative region in the antimicrobial susceptibility testing market in 2017 due to the emergence of a multidrug resistant strain of Salmonella in the U.S. For instance, according to the Centers for Disease Control and Prevention (CDC), September 2018, around two million people are infected with antibiotic-resistant bacteria in the U.S. annually and around 23,000 people die as a result. Moreover, government agencies in the U.S. have taken steps to prevent and control antibiotic resistance, which is expected to increase the adoption of antimicrobial susceptibility testing in the country. Asia Pacific antimicrobial susceptibility testing market revenue is expected to foresee significant growth over the forecast period due to high prevalence of microbial infections and increasing consumption of antibiotics, eventually developing resistance among the population. According to a WHO report, in 2014, multidrug-resistant tuberculosis rates were high in India and treatment for the disease is generally limited. Click To Reading More On Antimicrobial Susceptibility Testing Market About Coherent Market Insights: Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us: Mr.Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email:[email protected] 1/29/2019 Companion Diagnostics Market Breaking Down Into Type, Application And Regions 2018-2026Read NowCompanion diagnostic (CDx) is a diagnostic tool used to determine the suitability of a drug therapy to the patient. It has become a critical part of targeted cancer therapy that allows for development of personalized therapy can be developed and administered to the patient. Whole blood samples, tissues samples, or buccal samples are collected and tested for diagnosis and identification of targeted disease biomarker. CDx is usually utilized in identifying genetic mutations and the health and treatment approach implications. In July 2016, the U.S. FDA released a draft guideline for development of a therapeutic product accompanying an IVD companion diagnostic. Companion diagnostics include Gleevec (imatinib mesylate) and BCR-ABL LDT and DAKO C-KIT PharmDx, Herceptin (trastuzumab) and DAKO Herceptest; and Nolvaldex (tamoxifen) and laboratory-developed estrogen receptor positive test.
Download PDF Brochure of This Business Report @ https://www.coherentmarketinsights.com/insight/request-pdf/109 Market Dynamics Companion diagnostics are beneficial for pharmaceutical companies who face challenges with respect to high drug development cost, safety and outcome of clinical trials, and long product approval time. Companion diagnostics lowers development costs, improves time to market and enhances drug safety by enabling rapid identification of target biomarker and the most effective drug therapy. For patients, the technology provides better treatment outcomes and lower morbidity risk. Use of technologies such as PCR, immunohistochemistry, and gene sequencing has enabled accurate diagnosis and determination of targeted cancer therapy. As the CDx tests also aid in revealing the off-target effects of a drug along with identification of a molecular target, CDx have become and indispensable tool for oncologists. Research collaborations to improve the time to market the product An integrated and more evidence-based approach is driving partnerships in the global companion diagnostics market. According to Wildwood Ventures Ltd., the number of global deal in companion diagnostics market has increased from 13 in 2007 to 66 in 2013. Since, developing CDx test along with drug therapy is a capital intensive and complex process, industry players are collaborating to leverage on each other’s expertise. For instance: • Invivoscribe Technologies Inc., collaborated with Novartis AG and Astellas Pharma Inc. to develop companion diagnostics for their drugs under pipeline. • Invivoscribe also announced a long-term partnership with Thermo Fisher Scientific in January 2017, develop and commercialize IVD assays for Applied Biosystems® 3500 Dx Series Genetic Analyzers. Invivoscribe Technologies Inc. is a global company engaged in providing clonality and biomarker test solutions for oncology and personalized molecular diagnostics. • AstraZeneca plc entered into a deal with Abbott Laboratories, Inc. in 2015, to develop a companion diagnostic test for tralokinumab, used for treating severe asthma. • Singulex, Inc. entered into a strategic collaboration with QIAGEN N.V. in January 2017 to develop companion diagnostics using Singulex's proprietary Single Molecule Counting (SMC) immunodiagnostic platform Increasing number of research collaborations is expected to improve the time to market of highly effective targeted drug therapies. This would in-turn augment the growth of companion diagnostics market. Market Taxonomy This report segments the global companion diagnostics market on the basis of application, technology, and geography. On the basis of application, the market is categorized into breast cancer, lung cancer, colorectal cancer, gastric cancer, melanoma, and others. On the basis of technology, the market is segmented into immunohistochemistry, real-time PCR, gene sequencing, Fluorescence in situ hybridization (FISH), and others. For comprehensive understanding of market dynamics, the global companion diagnostics market is analyzed across key geographical regions namely North America, Europe, Asia Pacific, Latin America, Africa, and Middle East. Each of these regions is analyzed on basis of market findings across major countries in these regions for a macro-level understanding of the market. Detailed Segmentation: Global Companion Diagnostics Market, By Application: • Breast Cancer • Lung Cancer • Colorectal Cancer • Gastric Cancer • Melanoma • Others Global Companion Diagnostics Market, By Technology: • Immunohistochemistry • Real-time PCR • Gene Sequencing • FISH • Others Global Companion Diagnostics Market, By Geography: • North America • Latin America • Europe • Asia Pacific • Middle East • Africa Else place an Enquiry Before Purchase " Companion Diagnostics Market Size, Share, Outlook, Forecast" Report @ https://www.coherentmarketinsights.com/insight/talk-to-analyst/109 About Coherent Market Insights: Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us: Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email: [email protected] 1/29/2019 Dental Equipment Market: Pin Point Analysis Of Changing Competition Dynamics 2024Read NowPractice of dentists has shifted from being focused on disease treatment to preventive measures. This change in market dynamics is acting as a catalyst for development of new technologies for diagnosis and treatment of dental issues Growing awareness about dental care among consumers has translated into rising number of routine-check-ups and growing spending on maintaining oral health. This is in turn spurring demand for dental care equipment, including dental lasers, imaging systems, and computer-aided design and computer-aided manufacturing (CAD/CAM) systems.
Market Dynamics Dental equipment finds extensive application in diagnosis and treatment of dental disorders such as dental cavities, gingival disease, and periodontal (gum) disease. Advent of 3D printing in dental industry creates a highly favorable environment conducive for market growth and helps dentists provide better services through use of highly efficient diagnostic and treatment tools. Moreover, growing public awareness about dental treatment options, coupled with increasing expenditure on dental care is driving patients to opt for preventive measures. According to a study published in the American Dental Association’s research paper of 2014, around 52.3% of adults in the U.S. visited a dentist every six months. Focus on enhancing patient’s experience through high-quality treatment outcomes is driving demand for dental equipment worldwide. Request For Sample Copy of Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/85 Development of CAD/CAM & 3D printing is expected to drive dental equipment market growth Incision during surgeries can be carried out precisely by using laser and electro surgery techniques. This will reduce the damage caused to tissues and will aid in faster healing. The time taken for prosthodontic restoration procedures has reduced to one day due to the development of CAD/CAM. By replacing conventional radiology equipment with digital radiology equipment equipped with picture archiving and communication systems (PACS), treatment records can be archived. Moreover, outcomes of dental treatments have improved due to 3D printing technology. When compared to the conventional CT systems, cone beam CT systems provides clear extra oral images and exposure to harmful X-rays will be minimal. Increasing preference for refurbished dental equipment impacting the growth of overall dental equipment market Budget constraints in emerging countries such as India, China, Brazil and Eastern European countries is driving demand for refurbished dental equipment. This aids the newly established dental clinics and laboratories to achieve cost-efficiency with quality throughput. New dental equipment such as cone beam CT systems, vacuums & compressors, cad/cam, digital X-ray units and laboratory equipment involve high capital investment. This may increase the cost of patient dental procedures, thus negatively impacting the number of patient visits. Therefore, most dentists and hospitals in emerging countries prefer refurbished equipment, which in turn helps them pass on the cost-saving benefits to their patients. Market players such as Danaher Corporation, Planmeca Oy, and Dentsply Sirona, Inc. must consider the cost parameters while targeting the cost-sensitive customer base in emerging countries that are projected to be highly lucrative dental equipment markets in the near future. Market Taxonomy This report segments the global dental equipment market on the basis of equipment type and end user. On the basis of equipment type, the market is classified as dental imaging equipment, dental lasers, dental laboratory equipment, hygiene maintenance devices, systems and parts, and others. End users of these equipment are hospitals, dental clinics, and dental laboratories. Global Key Players A-Dec Inc., 3M ESPE, Carestream Heath, Inc., Biolase Inc., Noble Biocare, Danaher Corporation, Ivoclar Vivadent AG, Dentsply Sirona, Inc., Henry Schein, Inc., Patterson Companies Inc., Planmeca Oy, and Institut Straumann AG. Detailed Segmentation: Global Dental Equipment Market, By Equipment Type: • Dental imaging equipment • Dental lasers • Dental laboratory equipment • Hygiene maintenance devices • Systems and parts • Other dental equipment Global Dental Equipment Market, By End User: • Hospitals • Dental clinics • Dental laboratories Global Dental Equipment Market, By Geography: • North America • Latin America • Europe • Asia Pacific • Middle East • Africa Request For Customization of Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/85 About Coherent Market Insights: Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us: Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email: [email protected] Breast imaging is a technique used to obtain high resolution visualization of breast tissues and associated diseases. Breast cancer is the leading cause of the breast disease that require immediate screening, which in turn is anticipate to boost growth of the breast imaging market. Breast cancer can occur both in men and women. Furthermore, it is majorly reported in females as compared to male. The most common breast imaging tests used to determine breast cancer and related disease are ultrasound, mammography, nuclear imaging MRI, and thermography. Furthermore, mammography is the most preferred imaging techniques for breast cancer diagnosis for the women of age 40 and above.
Increasing incidence of breast cancer is expected to be a major factor driving growth of the breast imaging market during the forecast period. According to the breastcancer.org, around 1 in 8 women develop breast cancer over the course of their lifetime. According to the same source, in 2017, an estimated 252,710 new cases of invasive breast cancer are expected to be diagnosed among women in the U.S. Increasing government initiatives such as awareness programs and funding for research and development to introduce advanced imaging technologies in the market are expected to propel the breast imaging market growth. Get HOLISTIC Request Sample Copy Of This Business Report: https://www.coherentmarketinsights.com/insight/request-sample/2040 For instance, in 2013, Avon Foundation, in partnership with NCI (National Cancer Institute) and the Center for Advancing Innovation funded US$ 250,000 to launch the Breast Cancer Start-up Challenge aimed at teams of business, engineering, medical/scientific, and computer science students, as well as small sized entrepreneurs to develop and commercialize advanced breast cancer inventions. However, side effects of radiation and installation cost of breast cancer imaging devices and facilities may hinder growth of the breast imaging market. Breast Imaging Market- Regional Analysis Regional segmentation of the global breast imaging market by Coherent Market Insights comprises North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to hold dominant position in the global breast imaging market, owing to increasing initiatives by government, presence of major players, and early adoption of advanced medical technologies in economies such as the U.S. and Canada. Europe is also expected to show significant growth in breast imaging market, owing to increasing prevalence of breast cancer among women in various economies of this region. According to a report by the UNICEF (The United Nations Children's Fund), around 41,000 new cases of women are diagnosed with breast cancer in England annually and become more common cancer observed in the women in England. Increasing awareness among the populace in Asia Pacific, along with a large population base is expected to position Asia Pacific as a high growth market in the near future. According to International Association of Cancer Registries, in 2012, over 600,000 new breast cancer cases were reported in Asia, accounting for 39% of all breast cancers diagnosed worldwide. Click To Reading More On Breast Imaging Market About Coherent Market Insights: Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us: Mr.Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email:[email protected] |
Details
Global Industry Research Experienced Professional Freelancer with a demonstrated history of working in the information technology and services industry. Skilled in Front Office, Customer Service, Marketing, Microsoft Office, and Social Media. Strong media and communication professional with a Bachelor of Commerce - BCom focused in Computer and Information Sciences and Support Services from Pune University. Archives
July 2020
Categories |